All You Need to Know About Bad Cholesterol (LDL)

Pick up any lipid profile report in India. Next to your LDL value there is a printed range — usually something like “< 100” or “100–129 desirable.”

That same range is printed on the report of a healthy 25-year-old with no risk factors, and on the report of a 52-year-old who had a heart attack last year.

Same range. Completely different targets.

This is the single most common misunderstanding about cholesterol, and it is the reason people walk out of a lab feeling reassured when they shouldn’t be — or frightened when they needn’t be.

This article explains what LDL actually is, what your report does and doesn’t measure, what your target should be, and what the current guidelines say about the claims you have been hearing online. Every number is traced to a named source, listed at the end.

LDL is not cholesterol. It is the boat.

Cholesterol is a fat. Your blood is mostly water. Fat does not dissolve in water, so cholesterol cannot simply float through your bloodstream on its own.

It needs a carrier. That carrier is a lipoprotein — a particle with a water-friendly shell and a fatty core. LDL, or low-density lipoprotein, is that carrier. It is the boat. Cholesterol is the cargo.

So when someone says “LDL is bad cholesterol,” they are being imprecise. LDL is a delivery vehicle. The problem is not that it exists; the problem is what happens when too many of these particles circulate for too long.

An LDL particle can cross into the wall of an artery and get retained there. Once retained, it triggers inflammation, and over years this builds into plaque. Plaque narrows arteries and, if it ruptures, causes heart attacks and strokes. That is the whole mechanism, in one paragraph.

What your report measures — and what it does not

Here is the part almost nobody explains. Your report shows LDL-C — the amount of cholesterol carried inside your LDL particles. It does not count the particles.

Think about the boats again. If I tell you a harbour contains 100 tonnes of cargo, you still do not know whether that is 10 large ships or 40 small ones.

Two people can have the identical LDL-C number on paper while carrying very different numbers of particles. And since it is the particle that enters the artery wall, particle count matters.

This is why a second test exists: apolipoprotein B (ApoB). Every atherogenic particle carries exactly one ApoB protein on its surface, so measuring ApoB effectively counts the particles.

The 2026 ACC/AHA dyslipidaemia guideline supports ApoB measurement to assess residual risk and guide treatment — particularly in people with diabetes, high triglycerides, or cardiovascular-kidney-metabolic syndrome who have already reached their LDL-C goal. In other words, a normal LDL-C does not always mean the job is done. [1]

ApoB is a real, guideline-supported test. Remember that, because it matters for the next section.

“My LDL is high, but my particles are large, so I am fine”

You have almost certainly seen this claim. It usually arrives with a recommendation: get an advanced lipid test that measures your LDL particle size. If your particles come back “large and fluffy” rather than “small and dense,” you are told you can relax about a high LDL.

Here is what the current guideline actually says.

“Routine advanced lipoprotein testing… to assess lipoprotein subclasses and parameters such as LDL-C particle size is not recommended.”

— 2026 ACC/AHA Guideline on the Management of Dyslipidemia [1]

That is not an opinion from a creator on the internet. That is the American College of Cardiology and the American Heart Association, in their 2026 guideline, stating that the particle-size test is not recommended for routine use.

Note carefully what is and is not being said:

• The guideline does support ApoB — which counts particles.
• The guideline does not support routine particle size testing.

These two tests get blurred together constantly, often by people selling the second one. They are not the same thing.

The honest, defensible position: a “large particle” result is not a safety certificate. It is not a reason to ignore an elevated LDL-C or ApoB, and no major guideline tells your doctor to manage your risk that way.

So what IS your target?

Your target depends on your cardiovascular risk — not on the range the lab printed.

2026 ACC/AHA (United States)

Who you are	LDL-C goal
Primary prevention, borderline or intermediate 10-year risk	< 100 mg/dL
Primary prevention, 10-year risk ≥ 10%	< 70 mg/dL
Established cardiovascular disease, not very high risk	< 70 mg/dL
Established cardiovascular disease, very high risk	< 55 mg/dL

Note that “very high risk” here means secondary prevention — you already have cardiovascular disease, often after a heart attack. [1]

2019 ESC/EAS (Europe), reaffirmed in the 2025 Focused Update

Risk category	LDL-C goal
Low risk	< 116 mg/dL
Moderate risk	< 100 mg/dL
High risk	< 70 mg/dL
Very high risk	< 55 mg/dL and at least 50% reduction from baseline

The 2025 ESC/EAS Focused Update changed how risk is assessed but states explicitly that the LDL-C treatment goals have not changed from 2019. [2]

Notice the European very-high-risk target has two conditions, not one. Reaching 55 mg/dL is not enough on its own if it is not also at least half your starting value.

What about India?

The Lipid Association of India (LAI) publishes its own consensus for Indian patients, and in places it is more aggressive than the Western guidelines — reflecting the earlier onset and higher burden of coronary disease in South Asians.

LAI defines an “extreme risk” category that the other guidelines do not: [3]

• Extreme risk, Group A: LDL-C < 50 mg/dL, with an optional goal of ≤ 30 mg/dL
• Extreme risk, Group B: LDL-C ≤ 30 mg/dL

I am quoting only the figures I could verify directly. If your doctor is using the LAI framework, ask which category you fall into and what number they are aiming for. Do not assume a European or American table applies to you unchanged.

The practical takeaway: two people can both have an LDL of 95 mg/dL. For one it is comfortably fine. For the other it is roughly double where it should be.

Lp(a) — the test most Indians have never heard of

This is new, and it may be the most useful thing in this article.

The 2026 ACC/AHA guideline now recommends that every adult have their lipoprotein(a), or Lp(a), measured at least once in their lifetime. It is a Class 1 recommendation — the strongest category the guideline uses — and the first time a US guideline has recommended this universally. [1]

Why it matters:

• Lp(a) is largely genetic. Diet and exercise barely move it.
• It is an independent risk factor — you can have a perfect LDL and still carry high risk from Lp(a).
• Roughly 1 in 5 people worldwide have an elevated level.
• It is a once-in-a-lifetime test for most people, because the level is stable.

If someone in your family had a heart attack young, or you have been told your cholesterol “looks fine” but heart disease runs in your family, this is the test to ask about. And if your level does come back high, whether your parents, siblings and children should be tested too is worth raising with your doctor — because the level is inherited. We cover this in full in our guide to Lp(a).

Most Indian lipid panels do not include it. You have to ask.

Why does LDL go up?

Three broad reasons — and the order matters, because the third one is the one people jump to first.

1. Genetics

Familial hypercholesterolaemia (FH) is an inherited condition that raises LDL from birth. It is not rare, it is widely underdiagnosed, and it is not caused by anything the person did. The 2026 guideline specifically emphasises earlier detection of inherited cholesterol disorders, and now recommends lipid screening for all children aged 9 to 11. [1]

If your LDL is very high and your diet is genuinely reasonable, this deserves investigation rather than another round of dietary guilt.

2. Another condition is driving it — “secondary causes”

This is the step most often skipped, and it is the one I would most want you to remember.

Conditions that raise LDL include: [6]

• Hypothyroidism (an underactive thyroid)
• Nephrotic syndrome
• Obstructive liver disease
• Cushing’s syndrome
• Growth hormone deficiency
• Anorexia nervosa
• Pregnancy

Medications that can raise LDL include cyclosporine, tacrolimus, amiodarone, glucocorticoids, danazol, protease inhibitors, anabolic steroids, retinoids, thiazide diuretics, thiazolidinediones and SGLT2 inhibitors. [6]

Standard clinical teaching for a patient with a newly elevated LDL is: take a diet history, review the medication list, and check a TSH level to rule out hypothyroidism. [6]

This matters because treating the hypothyroidism can bring LDL down substantially — often back to normal — without any cholesterol medication at all. If your LDL is high and nobody has checked your thyroid, that is a fair question to ask.

3. Diet

Yes, diet matters. But probably not in the way you have been told.

The ghee and seed oil question

This is where Indian health content on the internet goes to war, and both sides are overstating their case.

What the evidence actually shows

The AHA/ACC recommendation for people with elevated LDL is to limit saturated fat to 5–6% of total daily calories. For context, typical American intake is around 11% — roughly double. [4]

And the substitution effect is substantial. From the 2017 American Heart Association Presidential Advisory on Dietary Fats and Cardiovascular Disease: [4]

• Replacing saturated fat with polyunsaturated fat reduced cardiovascular events by roughly 30% in randomised controlled trials — an effect the advisory describes as similar to what statin therapy achieves.
• In prospective cohort studies, substituting polyunsaturated fat was associated with about a 25% lower risk of coronary heart disease; monounsaturated fat, about 15%.

What this means for ghee

Ghee is high in saturated fat. That is simply its composition, and no amount of cultural affection changes it.

But here is the nuance that gets lost: no single food determines your LDL. Your total saturated fat across the whole day does.

One teaspoon of ghee in your dal is not the thing driving your cholesterol. The full picture is ghee plus malai plus red meat plus biscuits plus the palm oil in bakery items — added up across the day, every day.

So the useful question is not “is ghee good or bad.” It is: what percentage of my day’s calories is coming from saturated fat, from all sources combined?

What this means for seed oils

The claim that seed oils are “poison” is not supported by the evidence above. The same research that indicts excess saturated fat shows that replacing it with unsaturated fat — which is what most seed oils provide — lowers LDL and reduces cardiovascular events. [4]

That does not make deep-fried food healthy. Repeatedly reheated frying oil is a genuine issue, and ultra-processed foods cooked in these oils carry their own problems. But the oil is not a toxin because it came from a seed.

Neither ghee nor seed oil is the villain. The quantity of saturated fat, and what you replace it with, is what the evidence actually points to.

What genuinely lowers LDL

Soluble fibre — with real numbers

A dose-response meta-analysis of randomised controlled trials found: [5]

• Each additional 5 g/day of soluble fibre lowered LDL-C by 5.57 mg/dL (95% CI −7.44 to −3.69)
• Pooled effect versus placebo: −8.28 mg/dL
• Maximum effect at 10 g/day: −10.75 mg/dL — after which the benefit plateaued

That plateau is worth knowing. Going from 0 to 10 g/day of soluble fibre is where the benefit lives. Going from 10 to 20 g/day will not double it.

Good Indian sources of soluble fibre: oats, barley, rajma, chana, all dals, psyllium husk (isabgol), apples, guava, flaxseed.

Hitting 10 g of soluble fibre a day from food alone takes some planning, which is why psyllium husk is often the practical shortcut — it is almost entirely soluble fibre, and a couple of teaspoons in water gets you a meaningful share of the daily target.

Replace, do not just remove

Cutting saturated fat and replacing those calories with refined carbohydrates does not help. The benefit in the trials came from substitution with unsaturated fat. [4]

Physical activity, body weight, and not smoking

These move lipids modestly on their own but substantially change overall cardiovascular risk — which, as the targets section showed, is what actually determines your LDL goal in the first place.

Medication, when it is indicated

For context on what your doctor means when discussing intensity of treatment, the ACC/AHA classification is: [7]

• High-intensity statin therapy: approximately ≥ 50% LDL-C reduction from baseline
• Moderate-intensity statin therapy: 30% to < 50% reduction

I am a Nursing Officer, not your prescriber. Which medication, which dose, and whether you need one at all is a decision for you and your doctor. But knowing these two numbers lets you follow the conversation instead of just nodding through it.

Reading your own report properly

Do you need to fast?

Traditionally labs asked for 9–12 hours of fasting. That requirement has softened — research has questioned how much it adds, and many laboratories now accept non-fasting samples. Follow whatever instruction your doctor or lab gives you, and be consistent between tests so your results are comparable.

Your LDL was probably calculated, not measured

Most labs do not measure LDL directly. They calculate it, usually using the Friedewald equation. It has known limitations: [8]

• It becomes unreliable when triglycerides exceed 400 mg/dL
• It underestimates LDL-C when LDL is very low, below about 25 mg/dL

Newer equations — the Martin/Hopkins method in particular — handle these situations more accurately.

Practical point: if your triglycerides are high, your calculated LDL may not be trustworthy. That is a legitimate thing to raise with your doctor, and a direct LDL measurement or an ApoB may be more informative.

Compare like with like

Different labs use different methods and different equations. A jump between two reports from two different labs may partly reflect the labs, not your arteries. Where possible, track trends from the same laboratory.

Questions worth asking your doctor

1. Which risk category am I in, and what is my LDL target — not the lab’s printed range?
2. Has my thyroid (TSH) been checked to rule out a secondary cause?
3. Should I have ApoB measured, given that LDL-C alone can understate risk?
4. Should I have Lp(a) measured once, as the 2026 guideline recommends?
5. My triglycerides are high — is my calculated LDL reliable, or should it be measured directly?
6. Is there a family history that suggests familial hypercholesterolaemia?

The three things to take away

1. The lab’s printed range is not your target. Your target comes from your risk.
2. “Large particles” is not a safety certificate. The 2026 ACC/AHA guideline does not recommend routine particle-size testing. ApoB — which counts particles — is a different test, and that one is supported.
3. Neither ghee nor seed oil is the villain. Total saturated fat across your whole day, and what you replace it with, is what the evidence points to.

Sources

1. 2026 ACC/AHA/AACVPR/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Dyslipidemia. LDL-C goals by risk category; apoB to assess residual risk; universal once-in-lifetime Lp(a) measurement (Class 1); statement that routine advanced lipoprotein testing including LDL-C particle size is not recommended; lipid screening for all children aged 9–11. AHA Journals
2. 2019 ESC/EAS Guidelines for the Management of Dyslipidaemias, and the 2025 ESC/EAS Focused Update, which updated risk assessment but states the LDL-C treatment goals are unchanged from 2019. ESC summary
3. Lipid Association of India — extreme risk categories: Group A LDL-C < 50 mg/dL with optional goal ≤ 30 mg/dL; Group B ≤ 30 mg/dL. Consensus Statement IV, J Clin Lipidol 2024
4. Sacks FM et al. Dietary Fats and Cardiovascular Disease: A Presidential Advisory From the American Heart Association. Circulation. 2017. Replacing saturated fat with polyunsaturated fat reduced CVD events by about 30% in randomised trials, similar to statin therapy; ~25% lower CHD risk with polyunsaturated substitution and ~15% with monounsaturated in cohort studies; limit saturated fat to 5–6% of daily calories in people with elevated LDL. Circulation
5. Soluble fiber supplementation and serum lipid profile: a systematic review and dose-response meta-analysis of randomized controlled trials. Advances in Nutrition. 2023. −5.57 mg/dL LDL-C per 5 g/day (95% CI −7.44 to −3.69); pooled −8.28 mg/dL; maximum −10.75 mg/dL at 10 g/day. ScienceDirect
6. Endotext — Approach to the Patient with Dyslipidemia. Secondary causes of elevated LDL-C; medications that raise LDL-C; recommendation to take a diet history, review medications and check TSH. NCBI Bookshelf
7. 2018 ACC/AHA Guideline on the Management of Blood Cholesterol. Statin intensity definitions: high-intensity approximately ≥ 50% LDL-C reduction; moderate-intensity 30% to < 50%.
8. Friedewald equation limitations — unreliable above triglycerides of 400 mg/dL; underestimates LDL-C at very low levels; the Martin/Hopkins calculation is more accurate in these situations.

A note on how this article is written

Every figure above was checked against the source named beside it. Where guidelines disagree — as the American and European ones do on the lowest risk category — both are shown rather than one being quietly picked.

Where I could not verify something, it is not in the article. The Lipid Association of India’s complete risk table is one such case: only the extreme-risk figures I could confirm directly are quoted, rather than filling in the rest from memory.

If you find an error in this article, tell me and I will correct it publicly. That is the standard I hold this work to.

Related reading

• Lp(a): the inherited heart risk most Indians never test
• ApoB, LDL, Non-HDL and HDL in plain language
• How to keep your heart younger